August 7-9, 2025
Graduate by Hilton Hotels
Minneapolis, Minnesota, USA
Join ISMRD at our 7th International Glycoproteinoses Conference: Together We Are Strong in Minneapolis, MN, USA from August 7-9, 2025. During these three days, families, patients, doctors, researchers and pharmaceutical companies will work together to strengthen our community and our common goals. New partnerships will be forged, the seeds of new plans and strategies will be sown, new attachments formed. Coming together during this conference will help us to become even stronger!
ISMRD is the leading world advocate for the nine Glycoproteinoses:
Alpha-Mannosidosis, Aspartylglucosaminuria (AGU), Beta-Mannosidosis, Fucosidosis, Galactosialidosis, Mucolipidosis ll Alpha/Beta, Mucolipidosis lll Gamma, Schindler Disease and Sialidosis.
The theme of our conference is “Together We Are Strong”. This is in keeping with ISMRD’s Mission of seeking to detect and cure the Glycoprotein Storage Diseases, and to provide a global network of support and information, through partnerships built with medicine, science and industry. We have always known that working together is our greatest strength.
For the Conference Program, plese visit this link.
For Conference Registration, please visit this link.
The National Organization for Rare Disorders (NORD) is offering financial assistance to US families traveling to the ISMRD 7th International Family and Scientific Conference to support a loved one with a rare disease. This assistance aims to alleviate the financial burden of attending this important event.
What NORD Covers:
Application Process:
We encourage all eligible families to take advantage of this generous opportunity. Please contact NORD on +1 860-556-2208 with any questions.
ISMRD’s 7th International Glycoproteinoses Conference advisory board is excited to release the Registration and Sponsorship Opportunities via the links below. Please note that sponsorship items will be assigned in a fair and balanced manner, based on the date the online application and payment are received, and the company’s priority points. Popular sponsorship items sell out quickly, so companies are encouraged to submit their applications early.
As a potential sponsor, please use the following links to access more information for ISMRD’s 7th International Glycoproteinoses Conference 2025:
1. Registration
Thank you to ISMRD’s International Glycoproteinoses Conference Current Sponsors:
Silver Sponsorship
Thank You to ISMRD’s International Glycoproteinoses Conference Past Sponsors:
Mallinckrodt Pharmaceuticals, EveryLife Foundation, Sanofi Genzyme, Office of Rare Diseses, JCR Pharmaceuticals, Moderna, Chiesi, PTC Therapeutics, Shire, Zymenex, Rock 4 Dakatah, Mercy Medical Airlift, National Institute of Health, Amicus Therapeutics, Washington University in St. Lois School of Medicine, National Institute of Neruological Disorder and Stroke, The Wagner Foundation, The Pernille Foundation, Dr. Charles Vite, Dr. Mark Haskins
Showcase your latest research! The poster submission window is now open for ISMRD’s 7th International Glycoproteinoses Conference.
We are looking for poster abstracts focused on Glycoproteinoses rare disease research. Academics, researchers, industry, government agencies, healthcare professionals, patient organizations, and other interested parties, such as students who have conducted rare disease or orphan product research studies or public health projects relevant in these rare diseases are invited to submit an abstract for inclusion in the poster hall.
This is a great opportunity to share your research findings! Before submitting your poster abstract, check out ISMRD’s Abstract Guidelines.
The deadline to submit your poster abstract is Wednesday, April 30, 2025
To submit a poster abstract, please visit the Abstract Submission Form.